Eoin advises clients on all aspects of EU and international competition law, including merger control, antitrust investigations and compliance issues. He works in a variety of sectors, including pharmaceuticals, consumer goods, financial services, telecoms and technology.

Eoin has played a key role in a number of significant merger control and antitrust matters. These include advising:

Bayer AG on the sale of its worldwide animal health business to Elanco Animal Health.

A client in relation to the European Commission’s investigation into European Government Bonds.

Linde on its merger with Praxair.